Novo Integrated Sciences Inc. (NASDAQ:NVOS) does about 3.44M shares in volume on a normal day but saw 21850192 shares change hands in Monday trading. The company now has a market cap of 6.65M USD. Its current market price is $0.12, marking an increase of 5.74% compared to the previous close of $0.12. The 52 week high reached by this stock is $3.32 whilst the lowest price level in 52 weeks is $0.10. The script in recent trading has seen the stock touch a high of $0.129 and a low of $0.1185.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
Novo Integrated Sciences Inc. (NVOS) has a 20-day trading average at $0.1601 and the current price is -96.28% off the 52-week high compared with 22.54% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.2045 and its 200-day simple moving average is $1.2402. If we look at the stock’s price movements over the week, volatility stands at 16.04%, which increases to 18.57% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 32.36 to suggest the stock is neutral.
The current price level is -25.22%, -40.41%, and -90.13% away from its SMA20, SMA50, and SMA200 respectively, with the NVOS price moving above the 50-day SMA on January 23. Novo Integrated Sciences Inc. (NVOS) stock is down -6.16% over the week and -44.04% over the past month. Its price is -38.64% year-to-date and -90.65% over the past year.
Outstanding shares total 29.82M with insiders holding 59.78% of the shares and institutional holders owning 1.37% of the company’s common stock. The company has a return on investment of -7.90% and return on equity of -28.00%. The beta has a value of -0.20. Price to book ratio is 0.08 and price to sales ratio is 0.29.
According to a U.S. Securities and Exchange Commission filing, Vanguard Total Stock Market Index has reduced its position in Novo Integrated Sciences Inc. (NVOS) to 174,830 shares, mirroring a recent drop by -31.69%. Vanguard Total Stock Market Index dumped 81110.0 shares of Novo Integrated Sciences Inc. common stock bringing its total worth to about $35141.0 at the end of recent close, SEC documents show.
